Skip to content
Dosage GuideResearch Reference

Magainin 2 Dosage

Research-based dosing protocols, timing guidance, and reconstitution reference for Magainin 2. All information is for educational purposes only.

Quick Answer

Clinical trials of the Magainin analog Pexiganan (MSI-78) used topical applications of 0.8% cream twice daily for up to 2 weeks. Due to Magainin's rapid degradation, systemic dosing is not typically performed. Research formulations often involve liposomal encapsulation or modifications to enhance stability. No established human dose-ranging trials exist for Magainin itself beyond topical applications of analogs like Pexiganan.

→ Magainin 2 Benefits→ Magainin 2 Side Effects→ Full Magainin 2 Profile
Table of Contents

Standard Dosage Range

Research dosing range: Topical: 0.8% cream, 2× daily (Pexiganan)

Educational reference only

These dosage ranges are derived from preclinical research and community protocols. No human clinical dose-ranging trials have established therapeutic doses for most research peptides. Always consult a qualified healthcare provider before starting any peptide protocol.

Dosage by Use Case

Diabetic Foot Ulcer (Topical, as Pexiganan)

0.8% cream2× daily
Duration

Up to 2 weeks

Pexiganan (MSI-78), a Magainin analog, was used in Phase III trials for this application. Apply topically to the affected area.

Topical Antimicrobial (Experimental)

Concentration variesAs needed
Duration

Limited data

Magainin and derivatives are being explored in wound dressings and topical formulations. Concentrations and application frequency vary significantly across studies.

Anti-Biofilm Applications (Experimental)

Concentration variesDependent on application
Duration

Limited data

Research explores Magainins in disrupting biofilms. Concentrations used in in-vitro and in-vivo models differ.

Timing & Frequency

Topical applications are generally timed consistently (e.g., morning and evening) after cleaning the affected area. Magainin's short half-life limits its use in sustained systemic applications without modification.

Cycle Guidance

For topical applications like Pexiganan, treatment duration is typically limited to 2 weeks based on clinical trial protocols. Due to the lack of long-term human data, longer cycles are not established.

Reconstitution Reference

Quick reference for reconstituting Magainin 2. For custom vial sizes and concentrations, use the Reconstitution Calculator.

Common Vial SizeN/A (typically not supplied in lyophilized form)
BAC Water VolumeN/A
Concentration & DrawN/A
StorageDependent on formulation (e.g., cream, solution). Follow manufacturer guidelines.
StabilityDependent on formulation. Formulated products should be stored as directed.
Use the Reconstitution Calculator → for precise injection volumes based on your exact vial size, water volume, and desired dose.

Frequently Asked Questions

What is the dosage of Magainin for treating diabetic foot ulcers?
Clinical trials used a Magainin analog, Pexiganan (MSI-78), as a 0.8% cream applied topically twice daily for up to 2 weeks. Direct Magainin dosing for this purpose is not established.
Can Magainin be taken orally?
Due to Magainin's susceptibility to enzymatic degradation, oral administration is not practical without modifications like encapsulation. Systemic delivery is challenging without addressing its rapid breakdown.
How should I store Magainin?
Storage depends on the formulation of Magainin. If it is in a formulated cream or solution, follow the manufacturer's instructions. Lyophilized Magainin should be stored as directed by the supplier.

Last updated: 2026-02-19